Hikma and FAES Farma enter into exclusive licensing agreement for the commercialisation of Bilastine…
Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, announces the signing of an exclusive US license agreement with FAES Farma S.A. to…
Read More...
Read More...
